“To raise new questions, new possibilities, to regard old problems from a new angle, requires creative imagination and marks real advance in science.” Albert Einstein stated these profound words years ago. Scientist and leaders in cancer research must ask many challenging, difficult questions. They have to look at cancer with a new eye and perspective. If they dare to think and step outside the box, enormous amounts of development, research and answers will open the door to solutions and healing methods for cancer.
Seattle Genetics helps doctors through clinical trials and products focus on cancers. The company is advancing antibodies with scientific know how using ADC an antibody-drug conjugate. Genetics primary focus is the patient. Keeping a person healthy while undergoing treatment is their primary focus. Creative exploration, research and developing advanced and improved drugs also top the primary goals for this company.
Dr. Clay Siegall is a scientist and now the CEO and co-founder of Seattle Genetics. As a former scientist who worked on cancer and targeting techniques, he started the company with the idea of improving the research on pinpointing cancer cells, developing drugs to destroy cancer in designated areas and creating innovative ways of wiping out the cancer cells. In 1998 Clay B. Siegall, Ph.D., co-founded Seattle Genetics. He’s helped secure over $330 million by going to private and public institutions and organizations enlisting their help in the fight against cancer. Additionally, joint efforts and alliance through agreements with global companies such as Genentech, Medimmune, CuraGen, Bayer and Progenics secured more than 65 million since 2001. Before Dr. Siegall worked with Bristol-Myers Squibb Pharmaceutical Research Institute for over 6 years. Previously, he directed many projects at the National Cancer Institute for over 3 years.
The commitment and enthusiasm of Dr. Siegall and other innovative minds at the helm of a forward thinking company like Seattle Genetics is a positive source of information and hope for everyone involved in the cancer fight.